Unable to display view head.php file not found.
Unfortunately, however, despite the beneficial effects of torcetrapib on the lipids in ILLUMINATE, there were serious adverse effects. As shown in the Kaplan-Meier plot in the Figure, the 2 “time to first major cardiovascular (CV) event”-free curves diverge, but unfortunately in the wrong direction. There was a hazard ratio of 1.25 (p<0.001), meaning a 25% increased risk with torcetrapib versus that in placebo.
J Clin Lipidol. 2011; 5(6).